HomeIMNM • NASDAQ
add
Immunome Inc
Previous close
$20.36
Day range
$20.17 - $20.56
Year range
$5.15 - $27.65
Market cap
2.30B USD
Avg Volume
1.13M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 12.09M | 15.75% |
Net income | -69.90M | 12.90% |
Net profit margin | — | — |
Earnings per share | -0.76 | 31.53% |
EBITDA | -62.23M | -12.85% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 653.48M | 200.72% |
Total assets | 683.19M | 184.38% |
Total liabilities | 48.84M | -17.32% |
Total equity | 634.34M | — |
Shares outstanding | 113.13M | — |
Price to book | 3.63 | — |
Return on assets | -31.99% | — |
Return on capital | -34.69% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -69.90M | 12.90% |
Cash from operations | -47.95M | -14.01% |
Cash from investing | -4.00M | -140.98% |
Cash from financing | 432.80M | 2,054.82% |
Net change in cash | 380.84M | 3,217.32% |
Free cash flow | -21.08M | -38.60% |
About
Founded
2006
Headquarters
Website
Employees
177
